Groth P E
Am J Hosp Pharm. 1975 Jan;32(1):26-30.
Health providers in a four-state area who had utilized the Nebraska Regional Drug Information Service were surveyed to determine: (1) if providers would pay a fee for drug information services; and (2) if they would prefer a per-call fee or an annual subscription fee. Of 1,000 questionnaires mailed, approximately 500 were returned and analyzed. Results indicated that 52% of those responding felt that the drug information service provided direct benefits to patients. The service fee preferred most was $2.00 to $5.00 per call or $25.00 per year. Actual operating cost data showed that a per-call charge of $2.50 would not permit the service to break even. However, it was projected that the service would break even if it charged an annual fee of $25.00.
对四个州地区使用内布拉斯加区域药品信息服务的医疗服务提供者进行了调查，以确定：（1）提供者是否愿意为药品信息服务付费；（2）他们更喜欢按次收费还是年度订阅费。在邮寄的1000份问卷中，约500份被收回并进行了分析。结果表明，52%的受访者认为药品信息服务为患者带来了直接益处。最受欢迎的服务费是每次通话2.00美元至5.00美元或每年25.00美元。实际运营成本数据显示，每次通话收取2.50美元的费用无法使该服务实现收支平衡。然而，预计如果收取25.00美元的年费，该服务将实现收支平衡。
